Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Inflexxion developed evidence-based clinical assessment tools and data analytics platforms used by healthcare organizations to assess addiction risk, monitor prescription drug misuse/abuse trends, support post-market surveillance of pharmaceuticals—especially opioids—and inform public policy. Their NAVIPPRO system provided real-time national surveillance of substance abuse patterns. The company’s products are widely adopted by addiction treatment centers, chronic pain clinics, regulatory authorities, pharmaceutical companies for REMS/risk management programs.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Inflexxion.